Press Resease

Hemodialysis Vascular Grafts Market - Global Industry Analysis

Hemodialysis Vascular Grafts Market Size, Share & Trends Analysis Report - By Raw Material (Polytetrafluoroethylene, Polyester, Biological Materials, and Polyurethane) - Global Industry Perspective, Comprehensive Analysis, and Forecast, 2020 – 2026

Published Date: 24-Aug-2020 Category: Medical Device Report Format : PDF Pages: 110 Report Code: ZMR-3942 Status : Published

Global Hemodialysis Vascular Grafts market, which accrued nearly 310 (USD Million) in 2019, is set to record the CAGR of nearly 5.2% over the period from 2020 to 2026

Description

The global Hemodialysis Vascular Grafts market, which accrued nearly 310 (USD Million) in 2019, is set to record the CAGR of nearly 5.2% over the period from 2020 to 2026. The report offers assessment and analysis of the Hemodialysis Vascular Grafts market on a global and regional level. The study offers a comprehensive assessment of the market competition, constraints, sales estimates, opportunities, evolving trends, and industry-validated data. The report offers historical data from 2017 to 2019 along with a forecast from 2020 to 2026 based on revenue (USD Million).

Introduction

Hemodialysis vascular access dysfunctioning is a key reason for illness in the patients having hemodialysis and it also contributes notably towards total end-phase renal disorder expenses. This has resulted in huge demand for hemodialysis vascular grafts. Moreover, rise in the occurrence of kidney ailments, acceptance of bio-engineered vascular grafts, and product innovations have raised the product penetration in healthcare sector globally in the recent years. Furthermore, less availability of kidney donors has resulted in patients opting for hemodialysis, thereby steering the demand for hemodialysis vascular grafts.

Market Growth Dynamics

A prominent awareness about the advantages of using vascular grafts during hemodialysis procedures for patients with kidney disorders will drive the market growth over the estimated timeframe. In addition to this, patients prefer hemodialysis methods over kidney transplantations due to the huge costs and this will create huge demand for the cost-effective vascular grafts. Apparently, these medical devices facilitate the proper blood flow, thereby ensuring accessibility of huge amount of blood required for performing hemodialysis.  This will steer the business growth over the years ahead.

Moreover, due to complications involved due to use of synthetic arteriovenous access grafts during hemodialysis, the demand for biological vascular grafts is gaining traction in hemodialysis as it reduces probabilities of getting infection as well as low chances of rejection. This will create new growth avenues for the market over the years to come. Apparently, improvement in healthcare infrastructure facilities witnessed in the emerging economies will unravel new horizons of growth for hemodialysis vascular grafts industry during the estimated timeline.

North American Market To Amass Huge Returns Over 2020-2026

The growth of the industry in North America during the forecast timespan is owing to huge healthcare spending along with massive utilization of tissue engineered vascular grafts as well as biological vascular grafts during hemodialysis in countries like the U.S. and Canada. Apart from this, rise in the number of patients suffering from chronic renal ailments will enlarge the market scope in the region over the coming years.

Key players leveraging the market growth are InnAVasc Medical, Inc., C. R. Bard, Inc., CryoLife, Inc., W.L. Gore & Associates, LeMaitre Vascular, Inc., Merit Medical Systems, Terumo Medical Corporation, Getinge AB, Vascular Genesis, Inc., and Proteon Therapeutics, Inc.

The global hemodialysis vascular grafts market is segmented as follows:

By Raw Material

  • Polyester
  • Polytetrafluoroethylene
  • Polyurethane
  • Biological Materials

By Region

  • North America
    • The U.S.
    • Canada
  • Europe
    • France
    • The UK
    • Spain
    • Germany
    • Italy
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Southeast Asia
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa
    • GCC
    • South Africa
    • Rest of Middle East & Africa

Table Of Content

  • Chapter 1. Preface
    • 1.1. Report Description and Scope
    • 1.2. Research Scope
    • 1.3. Research Methodology
      • 1.3.1. Market Research Process
      • 1.3.2. Market Research Methodology
  • Chapter 2. Executive Summary
    • 2.1. Hemodialysis Vascular Grafts Market, 2016–2026(USD Million)
    • 2.2. Hemodialysis Vascular Grafts Market: Snapshot
  • Chapter 3. Global Hemodialysis Vascular Grafts Market– Industry Analysis
    • 3.1. Hemodialysis Vascular Grafts Market: Market Dynamics
    • 3.2. Market Drivers
      • 3.2.1. Improvement in healthcare infrastructure facilities witnessed in the emerging economies will unravel new horizons of growth for hemodialysis vascular grafts industry during the estimated timeline.
      • 3.2.2. A prominent awareness about the advantages of using vascular grafts during hemodialysis procedures for patients with kidney disorders will drive the market growth over the estimated timeframe.
    • 3.3. Porter’s Five Forces Analysis
    • 3.4. Market Attractiveness Analysis
      • 3.4.1. Market attractiveness analysis By Raw Material
      • 3.4.2. Market attractiveness analysis By Application
  • Chapter 4. Global Hemodialysis Vascular Grafts Market– Competitive Landscape
    • 4.1. Company market share analysis
      • 4.1.1. Global Hemodialysis Vascular Grafts Market: company market share, 2019
    • 4.2. Strategic development
      • 4.2.1. Acquisitions & mergers
      • 4.2.2. New Product launches
      • 4.2.3. Agreements, partnerships, cullaborations, and joint ventures
      • 4.2.4. Research and development and Regional expansion
    • 4.3. Price trend analysis
  • Chapter 5. Global Hemodialysis Vascular Grafts Market–Raw Material Analysis
    • 5.1. Global Hemodialysis Vascular Grafts Market overview: By Raw Material
      • 5.1.1. Global Hemodialysis Vascular Grafts Market share, By Raw Material , 2019 and 2026
    • 5.2. Pulytetrafluoroethylene
      • 5.2.1. Global Hemodialysis Vascular Grafts Market by Pulytetrafluoroethylene, 2016–2026(USD Million)
    • 5.3. Pulyester
      • 5.3.1. Global Hemodialysis Vascular Grafts Market by Pulyester, 2016–2026(USD Million)
    • 5.4. Biulogical Materials
      • 5.4.1. Global Hemodialysis Vascular Grafts Market by Biulogical Materials, 2016–2026(USD Million)
    • 5.5. Pulyurethane
      • 5.5.1. Global Hemodialysis Vascular Grafts Market by Pulyurethane, 2016–2026(USD Million)
  • Chapter 6. Company Profiles
    • 6.1. C. R. Bard, Inc.
      • 6.1.1. Overview
      • 6.1.2. Financials
      • 6.1.3. Product Portfolio
      • 6.1.4. Business Strategy
      • 6.1.5. Recent Developments
        • 6.2. W.L. Gore & Associates
      • 6.2.1. Overview
      • 6.2.2. Financials
      • 6.2.3. Product Portfolio
      • 6.2.4. Business Strategy
      • 6.2.5. Recent Developments
    • 6.3. LeMaitre Vascular, Inc.
      • 6.3.1. Overview
      • 6.3.2. Financials
      • 6.3.3. Product Portfolio
      • 6.3.4. Business Strategy
      • 6.3.5. Recent Developments
    • 6.4. Global Bio-Chem Technology
      • 6.4.1. Overview
      • 6.4.2. Financials
      • 6.4.3. Product Portfolio
      • 6.4.4. Business Strategy
      • 6.4.5. Recent Developments
    • 6.5. Terumo Medical Corporation
      • 6.5.1. Overview
      • 6.5.2. Financials
      • 6.5.3. Product Portfolio
      • 6.5.4. Business Strategy
      • 6.5.5. Recent Development
    • 6.6. Getinge AB
      • 6.6.1. Overview
      • 6.6.2. Financials
      • 6.6.3. Product Portfolio
      • 6.6.4. Business Strategy
      • 6.6.5. Recent Development
    • 6.7. InnAVasc Medical, Inc.
      • 6.7.1. Overview
      • 6.7.2. Financials
      • 6.7.3. Product Portfolio
      • 6.7.4. Business Strategy
      • 6.7.5. Recent Development
    • 6.8. Vascular Genesis
      • 6.8.1. Overview
      • 6.8.2. Financials
      • 6.8.3. Product Portfolio
      • 6.8.4. Business Strategy
      • 6.8.5. Recent Development
    • 6.9. Merit Medical Systems, Inc.
      • 6.9.1. Overview
      • 6.9.2. Financials
      • 6.9.3. Product Portfolio
      • 6.9.4. Business Strategy
      • 6.9.5. Recent Development
    • 6.10. Cryulife, Inc.
      • 6.10.1. Overview
      • 6.10.2. Financials
      • 6.10.3. Product Portfolio
      • 6.10.4. Business Strategy
      • 6.10.5. Recent Development
    • 6.11. Proteon Therapeutics, Inc.
      • 6.11.1. Overview
      • 6.11.2. Financials
      • 6.11.3. Product Portfolio
      • 6.11.4. Business Strategy
      • 6.11.5. Recent Development

Methodology


Frequently Asked Questions

A prominent awareness about the advantages of using vascular grafts during hemodialysis procedures for patients with kidney disorders will drive the market growth over the estimated timeframe.

The CAGR of the industry is expected to be nearly 5.2% during the forecast timeline.

North America will contribute remarkably towards the global market share over the estimated timeline.

The key market players include InnAVasc Medical, Inc., C. R. Bard, Inc., CryoLife, Inc., W.L. Gore & Associates, LeMaitre Vascular, Inc., Merit Medical Systems, Terumo Medical Corporation, Getinge AB, Vascular Genesis, Inc., and Proteon Therapeutics, Inc.

Choose License Type

Request the coronavirus impact analysis across industries and markets

HappyClients

Office Address

Corporate Office

Zion Market Research 244 Fifth Avenue, Suite N202 New York, 10001, United States
Tel: +49-322 210 92714
USA/Canada Toll Free No.1-855-465-4651

Asia Pacific Office

3rd Floor, Mrunal Paradise, Opp Maharaja Hotel, Pimple Gurav, Pune 411061, Maharashtra, India
Phone No 020-46277770

Contact #

US OFFICE NO +1-386-310-3803
US/CAN TOLL FREE +1-855-465-4651
Email: sales@zionmarketresearch.com

We Are On Social